BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37383238)

  • 1. BCG vaccination policy, natural boosting and pediatric brain and CNS tumor incidences.
    Singh S; Diwakar A; Singh RK
    Front Immunol; 2023; 14():1174006. PubMed ID: 37383238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Trained Immunity" from
    Singh S; Kishore D; Singh RK
    Front Immunol; 2023; 14():1193859. PubMed ID: 37292217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal BCG vaccination in Ireland: evidence of its efficacy in the prevention of childhood tuberculosis.
    Kelly P; McKeown D; Clancy L
    Eur Respir J; 1997 Mar; 10(3):619-23. PubMed ID: 9072995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities.
    Faust L; Schreiber Y; Bocking N
    BMC Public Health; 2019 Nov; 19(1):1504. PubMed ID: 31711446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in Childhood Nontuberculous Mycobacterial Infections After Bacille Calmette-Guérin Coverage Drop: A Nationwide, Population-Based Retrospective Study, Finland, 1995-2016.
    Kontturi A; Soini H; Ollgren J; Salo E
    Clin Infect Dis; 2018 Sep; 67(8):1256-1261. PubMed ID: 29584893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
    Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
    Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacillus Calmette-Guérin vaccination at birth: Effects on early childhood infections, growth, and development.
    Kjærgaard J
    Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland.
    Sweeney E; Dahly D; Seddiq N; Corcoran G; Horgan M; Sadlier C
    BMC Infect Dis; 2019 May; 19(1):397. PubMed ID: 31072396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of protective effect of BCG vaccination in persons at low risk of tuberculosis in Nordic countries.
    Brantsaeter AB; Romanus V; Andersen PH; Heldal E
    Int J Tuberc Lung Dis; 2009 Apr; 13(4):440-5. PubMed ID: 19335948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the effect of the 2005 change in BCG policy in England: a retrospective cohort study, 2000 to 2015.
    Abbott S; Christensen H; Welton NJ; Brooks-Pollock E
    Euro Surveill; 2019 Dec; 24(49):. PubMed ID: 31822330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis vaccine BCG: the magical effect of the old vaccine in the fight against the COVID-19 pandemic.
    Aspatwar A; Gong W; Wang S; Wu X; Parkkila S
    Int Rev Immunol; 2022; 41(2):283-296. PubMed ID: 33960271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Bacille Calmette-Guerin vaccination policies in reducing infection and mortality of COVID-19: a systematic review.
    Obnial JC; Suzuki M; Escuadra CJ; Austria JT; Ponce MJM; Cunanan E
    Glob Health Res Policy; 2022 Nov; 7(1):42. PubMed ID: 36336688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of a change in infant BCG vaccination policy on adolescent TB incidence rates: A South African population-level cohort study.
    Fack C; Wood R; Hatherill M; Cobelens F; Hermans S
    Vaccine; 2022 Jan; 40(2):364-369. PubMed ID: 34872798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of bacille Calmette-Guérin immunisation programs in Australia.
    Khandaker G; Beard FH; Dey A; Coulter C; Hendry AJ; Macartney KK
    Commun Dis Intell Q Rep; 2017 Mar; 41(1):E33-E48. PubMed ID: 28385137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paediatric tuberculosis during universal and selective
    Kontturi A; Kekomäki S; Soini H; Ollgren J; Salo E
    Euro Surveill; 2021 Mar; 26(11):. PubMed ID: 33739257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between Bacillus Calmette Guerin Vaccination Policy and Coronavirus Disease-2019 (COVID-19) Incidence.
    Alyasin S; Kanannejad Z; Esmaeilzadeh H; Nabavizadeh H; Ghatee MA; Amin R
    Iran J Allergy Asthma Immunol; 2021 Feb; 20(1):106-113. PubMed ID: 33639625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosol vaccination with Bacille Calmette-Guerin induces a trained innate immune phenotype in calves.
    Guerra-Maupome M; Vang DX; McGill JL
    PLoS One; 2019; 14(2):e0212751. PubMed ID: 30794653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacille Calmette-Guérin (BCG) vaccination at birth and antibody responses to childhood vaccines. A randomised clinical trial.
    Nissen TN; Birk NM; Smits G; Jeppesen DL; Stensballe LG; Netea MG; van der Klis F; Benn CS; Pryds O;
    Vaccine; 2017 Apr; 35(16):2084-2091. PubMed ID: 28318766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of Bacillus Calmette-Guérin (BCG) vaccination in COVID-19 pandemic mortality: Epidemiological and Immunological aspects.
    Charoenlap S; Piromsopa K; Charoenlap C
    Asian Pac J Allergy Immunol; 2020 Sep; 38(3):150-161. PubMed ID: 32686943
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.